Neoplasms benign malignant and unspecified (incl. cysts and polyps) research hub

A 2-part phase 1/2 open-label trial evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of ODM-212 in combination with anti-cancer therapy in participants with advanced solid tumours

This study is testing a new medicine called ODM-212 alongside existing cancer treatments for people with advanced solid tumours. It aims to check if the treatment is safe, how the body handles it, and if it helps shrink tumours or slow their growth.